Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)
Clinical trial NCT04866680 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04866680
- Sponsor
- Institut de Cancérologie de Lorraine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-31
- Primary completion
- 2027-11-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.